baber/WOPTO huggingface dataset:
Patent MX-159650-A (MX)
Inventor: BLANQUET CLAUDE
IPC: B21B25/02
Filed: 1981-06-04
Abstract: A restraining assembly for holding back and then releasing a mandrel which supports a tube being rolled in a rolling mill has a fork supported by a carriage which is driven by two endless chains. The carriage is articulated to two opposite links of the chains and the separation of the fork from the mandrel takes place as the chains run around end wheels and the carriage is tilted. To control this movement of the carriage the fork is at the forward or downstream end of the carriage and an additional connection is provided between the carriage and another link of at least one chain, preferably with play in the direction of movement of the chain.
Patent NZ-205145-A (NZ)
Title: Lifebelt with positive retention system for occupant
Inventor: MAUCK LEE EDWARD
IPC: B63C/
Filed: 1983-08-04
Abstract: A life preserver comprising a buoyant toroidal body having spaced yieldable strap members surrounding at least a portion of the toroidal body, a length of rope extending around the inner periphery of the toroidal body and passing through the central portions of the strap members whereby the rope is maintained in a normal stowage position substantially adjacent the inner periphery of the toroidal body, the rope having the opposite ends thereof extending radially outwardly beyond the outer periphery of the toroidal body and through a passageway for connection with a retrieving cable whereby the rope may be moved radially inwardly against the force of the yieldable strap members to snugly engage the body of a victim disposed within the interior or central opening of the toroidal body to facilitate rescue of the victim without assist from the victim himself.
Patent NZ-220208-A (NZ)
Title: Preparation of r-2,2-r 1 ,r 2 -1,3-dioxolane-4-methanol or -carboxylic acid, the s-isomer, and preparation of metoprolol; microorganisms
Inventor: BERTOLA MAURO ATTILIO
IPC: C12P17/04
Filed: 1987-05-06
Abstract: Process for the preparation of R-2,2-R1, R2-1,3-dioxolane-4-methanol wherein R1 and R2 are H or alkyl groups or wherein R1 and R2 together with the carbon atom to which they are attached form a carbocyclic ring by subjecting a mixture of R- and S-2,2-R1, R2-1,3-dioxolane-4-methanol to the action of a micro-organism or substances derived therefrom having the ability for stereoselective consumption of S-2,2-R1, R2-1,3-dioxolane-4-methanol preferably until at least 80 wt% and more preferably all the S-2,2-R1, R2-1,3-dioxolane-4-methanol is consumed. Various micro-organisms of the genus Rhodococcus, Nocardia and Corynebacterium are disclosed as suitable for the purpose. The R-isomer is a valuable intermediate for stereospecific synthesis of various biologically active compounds including S-metoprolol.
Patent NZ-221060-A (NZ)
Title: 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol derivatives and pharmaceutical compositions thereof
Inventor: HAMER RUSSELL RICHARD LEE
IPC: A61P25/04
Filed: 1987-07-14
Abstract: There are described compounds of the formula <CHEM>  where (a) X is O or S; (b) R is H, loweralkyl, <CHEM> where Y is O or S; R2 is loweralkyl, cycloalkyl, bicycloalkyl, cycloalkenyl, aryl, arylloweralkyl, heteroaryl or heteroarylloweralkyl, R3 is H or lower alkyl or the group -NR2R3 taken as a whole is 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 4-thiomorpholinyl, 1-piperazinyl, 4-methyl-1-piperazinyl or 2-(2,6-dichlorophenylimino)-1-imidazolidinyl) and R4 is hydrogen, loweralkyl, arylloweralkyl, diarylloweralkyl, aryl or heteroaryl, (c) m is 1 or 2; (d) each Z is independently H, loweralkyl, halogen, nitro, -NH2, loweralkylcarbonylamino, arylcarbonylamino, loweralkoxycarbonylamino or loweralkylamino, and (e) R1 is H, loweralkyl, arylloweralkyl, heteroarylloweralkyl, cycloalkylmethyl or loweralkenylmethyl, with the proviso that when X is O, m is 1, Z is H and R1 is methyl, R is not -CONHCH3, -CONHC6H5, hydrogen, methyl or ethyl, and that when X is O, m is 1 and Z and R are both hydrogen, R is not hydrogen or methyl, and pharmaceutically acceptable acid addition salts thereof which are useful as memory-enhancing and analgesic agents.
Patent NZ-223007-A (NZ)
Title: Optically active tetrahydro-2-furanone compounds as microbicides for plants
Inventor: ECKHARDT W
IPC: A01N43/08
Filed: 1987-12-21
Abstract: The (aS,1'R) enantiomer and the (aR,1'S)(aS,1'R) pair of enantiomers and the (aR,1'R)(aS,1'R) diastereomer of the compound of the formula <IMAGE> are potent plant microbicides. They can be obtained partly from the racemate by physicochemical separation methods and partly by targeted chemical synthesis.
Patent NZ-229699-A (NZ)
Title: Skin- or hair-care composition comprising silica and an ester of a di, tri or tetrabasic (hydroxy)carboxylic acid
Inventor: FAIRHURST EDGAR
IPC: A61Q19/00
Filed: 1989-06-23
Abstract: A skin- or hair-care composition containing silica additionally comprises a C2-4 alkyl ester of a di, tri- or tetrabasic carboxylic acid or hydroxy-carboxylic acid (optionally acetylated). The alkyl ester may be dissolved in an aqueous solvent system.
Patent NZ-254007-A (NZ)
Title: Removal of radionuclides from titanium ores by heating the ore at elevated temperature with a substance which disperses onto the ore surface and carries the radionuclides with it
Inventor: ARAL HALIL
IPC: C22B34/12
Filed: 1993-07-28
Abstract: PCT No. PCT/AU93/00381 Sec. 371 Date Apr. 6, 1995 Sec. 102(e) Date Apr. 6, 1995 PCT Filed Jul. 28, 1993 PCT Pub. No. WO94/03160 PCT Pub. Date Feb. 17, 1994A process for facilitating the removal of impurities e.g. radionuclides, such as uranium and thorium, and/or one or more of their radionuclide daughters, from titaniferous material includes contacting the titaniferous material with one or more reagents at an elevated temperature selected to enhance the accessibility of at least one of the radionuclide daughters in the titaniferous material. The reagent(s) may be a glass forming reagent and is selected to form a phase at the elevated temperature which disperses onto the surfaces of the titaniferous material and incorporates the radionuclides and one or more radionuclide daughters. The titaniferous material may be, e.g., ilmenite, reduced ilmenite, altered ilmenite or synthetic rutile.
Patent NZ-279689-A (NZ)
Title: Substituted biphenyl derivatives, preparation and pharmaceutical compositions thereof
Inventor: CAGGIANO THOMAS JOSEPH
IPC: C07C311/08
Filed: 1995-01-25
Abstract: A compound of the following structure:   <IMAGE>   wherein, when R8=H: R1=alkyl, cycloalkyl, arylalkyl, aryl; R2=cycloalkyl, aryl, C3-C10 alkyl; X,Y=O, S(O)n, NH; Z=CHO, CO2R3, CONHR4R5, CN, COR6, H, halo, HCN, NHCONR4R5, CONR4OR5, CONR4NR5R6, 1-tetrazole, S(O)nOH, S(O)nNR3R4, C=NOH, C(=N(OH)NH2, OCONR7R6, P(O)(OR4)2, C(=N(YR3))R4, NH2, SH, OH, OS(O)2R3, C(=NYC(=O)R3)R4, C(O)CO2R3, C(O)CONR3R4, CH(OH)CO2R3, CHFCO2R3, CF2CO2R3, CH(OH)CONR3R4, CF2CONR3R4, C=NNH2, C(=NOC(=O)R3)R4, C(=NNHC(=O)R3)R4, C(=NOH)R3, C(=NNR3)R4, NHC(=O)R6 or C(O)CONH2; R3, R4, R5, R6, R7=hydrogen, alkyl, aryl, aryalkyl, cycloalkyl, or fluoroalkyl; or a compound of Structure I, as just defined, wherein: X,Y=CH2, O, S(O)n, or NH; Z and R8=CO2R3, CONR3, or R8 and Z are concatenated such that R8Z=C(O)NHNHC(O), (CH2)mC(=W), V(CH2)mC(=W), or VnCH=CH(CH2)nC(=W); where V=O, S(O)n, NH; W=O, NOH, NHNH2, NOC(O)CH3, or NNHC(O)CH3; n=0-2; and m=2-4 or pharmaceutically acceptable salts thereof, useful in the treatment of asthma, and allergic and inflammatory diseases, as well as methods of treatment and pharmaceutical compositions utilizing the same.
Patent NZ-283528-A (NZ)
Title: Azetidinone derivatives; medicaments; precursors
Inventor: KIRKUP MICHAEL P
IPC: C07C227/32
Filed: 1995-03-22
Abstract: Substituted azetidinone hypocholesterolemic agents of the formula   <IMAGE>   or a pharmaceutically acceptable salt thereof, wherein: Ar1 is R3-substituted aryl; Ar2 is R4-substituted aryl; Ar3 is R5-substituted aryl; Y and Z are independently -CH2-, -CH(lower alkyl)- or -C(dilower alkyl)-; A is -O-, -S-, -S(O)- or -S(O)2-; R1 is -OR6, -O(CO)R6, -O(CO)OR9 or -O(CO)NR6R7; R2 is hydrogen, lower alkyl or aryl; or R1 and R2 together are =O; q is 1, 2 or 3; p is 0, 1,2, 3 or 4; R5 is 1-3 substitutes independently selected from -OR6, -O(CO)R6, -O(CO)OR9, -O(CH2)1-5OR9, -O(CO)NR6R7, -NR6R7, -NR6(CO)R7, -NR6(CO)OR9, -NR6(CO)NR7R8, -NR6SO2-lower alkyl, -NR6SO2-aryl, -CONR6R7, -COR6, -SO2NR6R7, S(O)0-2-alkyl, S(O)0-2-aryl, -O(CH2)1-10-COOR6, -O(CH2)0-10CONR6R7, o-halogeno, m-halogeno, o-lower alkyl, m-lower alkyl, -(lower alkylene)-COOR6 and -CH=CH-COOR6; R3 and R4 are 1-3 substituents independently selected from R5, hydrogen, p-lower alkyl, aryl, -NO2, CF3 and p-halogeno; R6, R7 and R8 are hydrogen, lower alkyl, aryl or aryl-substituted lower alkyl; and R9 is lower alkyl, aryl or aryl-substituted lower alkyl; are disclosed, as well as a method of lowering serum cholesterol by administering said compounds, pharmaceutical compositions containing them, the combination of a substituted azetidinone and a cholesterol biosynthesis inhibitor for the treatment and prevention of atherosclerosis, novel intermediates and methods for preparing said intermediates.
Patent NZ-285244-A (NZ)
Title: Promotional gaming: prizes awarded if codes read from tokens match predetermined set
Inventor: BLUMBERG BARRY B
IPC: A63F3/08
Filed: 1995-05-02
Abstract: A promotional game wherein prizes are automatically and randomly awarded upon presentation of multiple tokens bearing machine readable codes. The random generation of prize awards will take place after the multiple inputs of machine readable codes include a set of inputs which match a preselected set of actuating codes.
Patent NZ-297420-A (NZ)
Title: Preparation of caprolactam
Inventor: FUCHS EBERHARD
IPC: C07D201/08
Filed: 1995-11-29
Abstract: An improved process for the preparation of caprolactam by heating 6-aminocapronitrile in the presence of a heterogenous catalyst and water under superatmospheric pressure without rapid deactivation of the catalysts used. The process further includes the addition of a low or high boiling alcohol in the heating phase, after which the products are obtained by distillation. The process further includes a method of working up the top and bottom products of the reactors to achieve higher yields.
Patent NZ-311760-A (NZ)
Title: Push-fit tube couplings
Inventor: DUDLEY STEVEN JOHN
IPC: F16L37/091
Filed: 1996-07-05
Abstract: tube coupling system comprises a coupling having a main body (2) which defines a tube receiving bore, the tube receiving bore being provided with a seal (4) to seal around the outer surface of a tube (T) received within the bore and being provided with tube gripping means such as a split ring (8) for engaging the outer surface of the tube. The system further comprises a release tool (21) which may be moved axially with respect to the bore to release the tube gripping means (8) from the tube (T). The release tool is removable and the tube gripping means has an outwardly facing tapering surface (28) which is engaged by a corresponding surface on the release tool. The tool is a two part or hinged sleeve to enable it to be placed over, and removed from, the tube (T).
Patent NZ-331536-A (NZ)
Title: use of a species of Coxiella or components thereof in preventing autoimmune disease in a mammal
Inventor: COWDEN WILLIAM BUTLER
IPC: A61P3/00
Filed: 1997-03-14
Abstract: One or more antigenic components of the species Coxiella or a species of Coxiella is used in the manufacture of a medicament for preventing, inhibiting, delaying onset or otherwise ameliorating the effects of an autoimmune disease in mammals or for prolonging the survival of islet tissue transplanted into a mammal. The preferred species of Coxiella is Coxiella burentii that can be in the form of a killed preparation.  The preferred antigenic component can be Q fever antigen
Patent NZ-331893-A (NZ)
Title: Water treatment method comprising adding hydrogen peroxide, a polyquaternary ammonium compound and intermittently chlorine or the like
Inventor: BROWN GEOFFREY A
IPC: C02F1/50
Filed: 1997-03-18
Abstract: This method of treating water is by adding to the water a shelf-stable composition of hydrogen peroxide and a polyquaternary ammonium compound, followed by intermittent treatment with chlorine-, bromine- or oxygen-releasing compounds.
Patent NZ-501218-A (NZ)
Title: Proteins isolated from plant genus Pentaclethra that have insecticidal activities and method of use
Inventor: CIGAN AMY L
IPC: C12N15/82
Filed: 1998-05-15
Abstract: Compositions and methods for controlling pests, particularly insect pests, are provided. The compositions comprise proteins isolated from plants of the genus Pentaclethra. Nucleotide sequences encoding the proteins are also provided. Such sequences find use in transforming organisms for control of pests.
Patent NZ-504954-A (NZ)
Title: Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
Inventor: PEYMAN ANUSCHIRWAN
IPC: C07C279/22
Filed: 1998-12-10
Abstract: Novel acylguanidine derivatives of formula (I) and their physiologically tolerable salts and their prodrugs are valuable pharmaceutical active compounds. They are vitronectin receptor antagonists and inhibitors of bone resorption by osteoclasts. They are suitable, for example, for the therapy or prophylaxis of diseases which are caused at least partially by an undesired extend of bone resorption, for example of osteoporosis. Preparation of compounds of formula (I), their use, in particular as pharmaceutical active ingredients, and pharmaceutical preparations comprising them are further disclosed.
Patent NZ-507259-A (NZ)
Title: Indole-2,3-dione-3-oxime derivatives for therapeutic use
Inventor: WATJEN FRANK
IPC: A61K31/404
Filed: 1999-03-30
Abstract: A compound useful in treating ischaemic diseases relating to the release of excitatory amino acids, such as spinal injury, traumatic brain injury, hypoxic or anoxic brain damage, ischaemia resulting from surgery and increased intracranial pressure for example. The compound has formula I. R1 represents hydrogen, alkyl or benzyl. R3 represents "Het", or a group of the formula II. "Het" represents a saturated or unsaturated, 4 to 7 membered, monocyclic, heterocyclic ring, which ring may be substituted with substituents selected from a halogen, alkyl, alkoxy, and oxo group. R31, R32, and R33 represents hydrogen, alkyl, or hydroxyalkyl. At least one of R31, R32, and R33 represents (CH2)n R34. R34 represents hydroxy, carboxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, cycloalkoxycarbonyl, cycloalkyl-alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, CONR35 R36, or "Het". R35 and R36 represents hydrogen, alkyl, alkenyl, alkynyl, hydroxyalkyl, cycloalkyl, aryl, aralkyl, or (CH2)n R37. R37 represents hydroxy, carboxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, cycloalkoxycarbonyl, cycloalkylalkoxycarbonyl, aryloxycarbonyl, or aralkoxycarbonyl. Alternatively, R35 and R36 together with the N-atom form a saturated 5- to 6-membered heterocyclic ring, optionally containing one additional N or O atom. n is 0, 1, 2, or 3. R5 represents phenyl, naphthyl, thienyl, or pyridyl, all of which may be substituted one or more times with substituents selected from the group consisting of halogen, CF3, NO2, amino, alkyl, alkoxy, phenyl and SO2 NR51 R52. R51 and R52 each represents hydrogen or alkyl; or R51 and R52 together with the N-atom to which they are attached form a saturated 4- to 7-membered monocyclic, heterocyclic ring, containing one additional N or O atom. "A" represents a ring of five to seven atoms fused with the benzo ring at the positions marked "a" and "b", and formed by the following bivalent radicals: a-NR6-CH2-CH2-b; a-CH2-NR6-CH2-b; a-CH2-CH2-NR6-b; a-NR6-CH2-CH2-CH2-b; a-CH2-NR6-CH2-CH2-b; a-CH2-CH2-NR6-CH2-b; a-CH2-CH2-CH2-NR6-b; a-NR6-CH2-CH2-CH2-CH2-b; a-CH2-NR6-CH2-CH2-CH2-b; a-CH2-CH2-NR6-CH2-CH2-b; a-CH2-CH2-CH2-NR6-CH2-b; or a-CH2-CH2-CH2-CH2-NR6-b; wherein R6 represents hydrogen, alkyl or CH2CH2OH.
Patent NZ-509429-A (NZ)
Title: Modified amino acid sequence of receptor provide other ligands to bind and stabilise the active state conformation of the receptor
Inventor: BEHAN DOMINIC P
IPC: C07D405/12
Filed: 1999-07-30
Abstract: Disclosed herein are techniques for directly identifying candidate compounds as agonists, partial agonists and/or, most preferably, inverse agonists, to endogenous, constitutively activated orphan G protein-coupled receptors. Such directly identified compounds can be utilized, most preferably, in pharmaceutical compositions.
Patent NZ-516471-A (NZ)
Title: Preserving a hemoglobin blood substitute with a transparent overwrap
Inventor: GAWRYL MARIA S
IPC: A61K38/42
Filed: 2000-07-07
Abstract: A method for preserving the stability of a hemoglobin blood substitute comprising maintaining the hemoglobin blood substitute in an atmosphere substantially free of oxygen. The method for preserving the deoxygenated hemoglobin blood substitute comprises maintaining the deoxygenated blood substitute in an oxygen barrier film overwrap package, wherein at least one face of the overwrap package comprises a transparent laminate material and wherein at least one other face of the overwrap package comprises a foil laminate material. The preserved deoxygenated hemoglobin blood substitute comprises a deoxygenated hemoglobin blood substitute and an oxygen barrier film overwrap package wherein at least one face of the overwrap package comprises a transparent laminate material and wherein at least one other face of the overwrap package comprises a foil laminate material.
Patent NZ-518917-A (NZ)
Title: Compounds and methods for treatment and diagnosis of chlamydial infection
Inventor: PROBST PETER
IPC: C07K19/00
Filed: 2000-12-04
Abstract: Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Chlamydial infection in patients and in biological samples.
Patent NZ-519787-A (NZ)
Title: Device for a flotation machine
Inventor: BELKE JEFFREY
IPC: B01F3/04
Filed: 2000-12-20
Abstract: A device for a flotation machine in which a drive shaft for mixing slurry and transporting air is driven by a drive arrangement and the drive shaft is provided with a bearing assembly and the drive shaft is at least partly hollow in the interior for transferring air to a rotor.  The drive shaft (7) is provided with at least one bearing (11) in a housing separated from at least one element (12) forming an air transfer chamber (13) around the drive shaft (7).  Further, the drive shaft (7) has at least one opening (16) in order to create an essentially continuous connection between the air transfer chamber (16) and the interior (17) of the drive shaft (7).
Patent NZ-523123-A (NZ)
Title: Methods of treating viral diseases with IL-18 and IL-18 combinations with anti-viral drugs
Inventor: ESSER KLAUS M
IPC: A61K38/00
Filed: 2001-06-01
Abstract: A polypeptide having at least 90% identity of the amino acid sequence of SEQ ID NO. 1 over the entire length of SEQ ID NO. 1 can be used in the preparation of a medicament for use in treating or preventing a disease caused by Influenza Virus, HIV, HSV, HPV, HAV, HBV or HCV in a mammal. Also the use of the polypeptide and either an antiviral agent , an immunomodulatory cytokine, or an immunogen derived from a viral protein or nucleotide sequence are described in the preparation of a medicament used in treating a disease caused by Influenza Virus, HIV, HSV, HPV, HAV, HBV or HCV in a mammal.
Patent NZ-524732-A (NZ)
Title: Expansion device for vapor compression system with variable orifice expansion device
Inventor: WIGHTMAN DAVID A
IPC: F16K3/08
Filed: 2001-09-14
Abstract: A vapor compression system having a line 19 for flowing heat transfer fluid, a compressor 12 and a condenser 14 both connected with the line. The vapor compression system also has an expansion device 18 connected with the line 19 for expanding the heat transfer fluid. The expansion device has a housing defining a housing orifice (not shown) and at least one ball (not shown) within the housing. The ball forms at least two channels, wherein each channel defines a channel orifice. The effective cross-sectional area of the one channel orifice is greater than the effective cross-sectional area of the other channel orifice. Moreover, the ball is movable between a first position and a second position, wherein the housing orifice is effectively made larger in the first position than in the second position. The vapor compression system also has an evaporator 16 connected with the line 19 for transferring heat from ambient surroundings to the heat transfer fluid.
Patent NZ-528575-A (NZ)
Title: Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides
Inventor: SZNAIDMAN MARCOS
IPC: C07H19/09
Filed: 2002-03-29
Abstract: A process for the preparation of 2Æ-deoxy-2Æ-halo-beta-L arabinofuranosyl nucleoside of formula (I), particularly 2Æ-deoxy-2Æ-halo-beta-L arabinofuranosyl thymine (L-FMAU), from L-arabinose, wherein: X is a halogen; and B is a pyrimidine, purine, heterocyclic or heteroaromatic base. Compounds of formula I have been found to be useful in the inhibition of viral DNA synthesis at the triphosphate level, probably by tight binding to viral polymerase.
Patent NZ-529056-A (NZ)
Title: Coating procedures
Inventor: STEWART JEFFREY WILLIAM
Filed: 2003-10-21
Abstract: A method of powder coating heat sensitive substrates is disclosed, which includes the steps of (a) heating the substrate sufficiently to enable its powder coating, (b) applying a coating of a powder ('the first powder coating") at least to an entire surface of the sufficiently heated substrate, (c) partially heat curing the first powder coating on said entire surface, (d) applying a subsequent powder coating (whether the same type of powder of different) ("the second powder coating") to the entire surface of the partially cured and still sufficiently heated first powder coating on said entire surface of the substrate, and (e) either (i) heat curing or (ii) heating and UV curing the second powder coating. Also included in the method is movement of the coated substrate relative to plural fixed infrared radiant heat sources spaced to provide a movement caused pulsing of exposure within the step of heat curing.